Savonix Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 14

Savonix General Information

Description

Developer of a digital neuropsychology platform intended to assess and monitor cognitive health. The company's platform delivers a mobile, evidence-based assessment of cognitive and emotional function and provides an accurate, accessible, real-time monitoring tool for professional cognitive screening of dementia, enabling healthcare providers to evaluate and leverage results to improve health and treatment outcomes.

Contact Information

Website
www.savonix.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Information Services (B2C)
Primary Office
  • 101 California Street
  • Suite 1525
  • San Francisco, CA 94133
  • United States
+1 (415) 000-0000

Savonix Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Savonix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Secondary Transaction - Private 01-May-2023 000.00 Completed Generating Revenue
6. Secondary Transaction - Private 000.00 Completed Generating Revenue
5. Later Stage VC (Series A3) 12-Mar-2021 00.00 000.00 00.00 Completed Generating Revenue
4. Later Stage VC (Series A1) 04-Sep-2019 000 000.00 0000 Completed Generating Revenue
3. Later Stage VC (Series A) 25-Apr-2019 00.00 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 18-Dec-2018 $9.6M $11.1M 000.00 Completed Generating Revenue
1. Seed Round 07-Dec-2017 $1.5M $1.5M 00.00 Completed Generating Revenue
To view Savonix’s complete valuation and funding history, request access »

Savonix Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A3 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A2 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series 4 0,000,000 00.000000 0.000 00.00 00.00 00 00.00 0.000
Series 3 00,000,000 00.000000 0.000 00.00 00.00 00 00.00 00.000
Series 2 6,002,002 $0.000100 0.02% $0.26 $0.26 1x $0.26 4.12%
Series 1 12,600,922 $0.000100 0.02% $0.41 $0.41 1x $0.41 8.64%
To view Savonix’s complete cap table history, request access »

Savonix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a digital neuropsychology platform intended to assess and monitor cognitive health. The company's platform
Other Healthcare Technology Systems
San Francisco, CA
16 As of 2023
000.00
00000000000 000.00

000000

ud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis au
00000 0000000000 000
San Jose, CA
00 As of 0000
000.00
00000000000 000.00

000000

am, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo cons
00000000000 00000000
San Francisco, CA
00 As of 0000
00.00
00000000000 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Savonix Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NeuroSky Formerly VC-backed San Jose, CA 00 000.00 00000000000 000.00
00000000 Formerly VC-backed San Francisco, CA 00 00.00 00000000000 00.00
000000000 000000 Venture Capital-Backed San Mateo, CA 000 00000 00000000000 00000
0000000 Venture Capital-Backed Washington, DC 00 000.00 000000 - 000 000.00
00000000 Corporation Bradbury, CA 00
You’re viewing 5 of 23 competitors. Get the full list »

Savonix Patents

  • 2

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Savonix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10188337-B1 Automated correlation of neuropsychiatric test data Inactive 22-Aug-2015 00000000
US-20190150819-A1 Automated correlation of neuropsychiatric test data Inactive 22-Aug-2015 00000000

Savonix Executive Team (12)

Name Title Board Seat Contact Info
Daniel Kogan Head of Technology
Joe Felter Advisor
You’re viewing 2 of 12 executive team members. Get the full list »

Savonix Board Members (10)

Name Representing Role Since
John Nackel Ph.D Wavemaker Three-Sixty Health Chairman 000 0000
You’re viewing 1 of 10 board members. Get the full list »

Savonix Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Savonix Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kickstart Ventures Corporate Venture Capital Minority 000 0000 000000 0
Plug and Play Tech Center Accelerator/Incubator Minority 000 0000 000000 0
Wanxiang Healthcare Investments Venture Capital Minority 000 0000 000000 0
Wavemaker Partners Venture Capital Minority 000 0000 000000 0
DEFTA Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial